{"id":10360,"date":"2021-11-03T14:45:00","date_gmt":"2021-11-03T11:45:00","guid":{"rendered":"https:\/\/roboforex.com\/blog\/?p=10360"},"modified":"2023-06-22T17:43:41","modified_gmt":"2023-06-22T14:43:41","slug":"how-did-pfizer-shares-react-to-q3-report","status":"publish","type":"post","link":"https:\/\/roboforex.com\/blog\/2021\/11\/03\/how-did-pfizer-shares-react-to-q3-report\/","title":{"rendered":"How Did Pfizer Shares React to Q3 Report?"},"content":{"rendered":"\n

This week two world-known pharma companies – Pfizer<\/a> and Moderna – will replace IT giants on the scene of quarterly reports. The former company has already reported its performance in July-September, and the latter will do it tomorrow.<\/p>\n\n\n\n

Was Q3 successful for Pfizer? How much anti-covid vaccine have they sold? What does the company expect from the current quarter? How did the shares react to the quarterly report? Let me try and give you some answers.<\/p>\n\n\n\n

<\/span><\/a>Pfizer report for Q3, 2021: revenue and profit grew by over 130%<\/span><\/h2>\n\n\n\n

On November 2nd, before the trading session began, an American pharma company Pfizer presented its report for Q3, 2021. I’d say that the statistics not just lived up to the forecasts of Wall Street analysts but exceeded them.<\/p>\n\n\n\n

No wonder that on the same day, the quotations of Pfizer (NYSE<\/a>: PFE) grew by 4.15% to $45.45. Since the beginning of the year – as we can see on the chart – the shares have grown by 23.5%, i.e. almost $9 per share.<\/p>\n\n\n\n

<\/span><\/a>Important report details<\/span><\/h3>\n\n\n\n